Annexon Biosciences is a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases.
At Annexon Biosciences, we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases. We are seeking a Vice President, Drug Safety and Pharmacovigilance to oversee and direct our portfolio of investigational compounds, ensuring patient safety in all clinical trials.
Annexon Biosciences is a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases.
Corcept Therapeutics